184 related articles for article (PubMed ID: 3065439)
1. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Thomsen T; Kewitz H; Pleul O
J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.
Thomsen T; Zendeh B; Fischer JP; Kewitz H
Biochem Pharmacol; 1991 Jan; 41(1):139-41. PubMed ID: 1986738
[No Abstract] [Full Text] [Related]
3. Spontaneous reactivation of phosphinylated human erythrocyte acetylcholinesterase and human serum butyrylcholinesterase.
Lawson MA; Lieske CN; Fox-Talbot MK; Meyer HG
Life Sci; 1985 May; 36(18):1715-20. PubMed ID: 3982230
[TBL] [Abstract][Full Text] [Related]
4. A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors.
Thomsen T; Kewitz H; Pleul O
Enzyme; 1989; 42(4):219-24. PubMed ID: 2698348
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine.
Thomsen T; Kaden B; Fischer JP; Bickel U; Barz H; Gusztony G; Cervos-Navarro J; Kewitz H
Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):487-92. PubMed ID: 1954303
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
8. [Catalytic properties of cholinesterases immobilized in N-phthalylchitosan and gelatin].
Kuznetsova LP; Nikol'skaia EB
Ukr Biokhim Zh (1978); 1995; 67(5):49-54. PubMed ID: 8830436
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues.
Marco JL; de los Ríos C; Carreiras MC; Baños JE; Badía A; Vivas NM
Bioorg Med Chem; 2001 Mar; 9(3):727-32. PubMed ID: 11310608
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of the interaction of the cholinesterase from the brain of the cabbage fly, the acetylcholinesterase from bovine erythrocytes and the butyrylcholinesterase from horse blood serum with organophosphorus inhibitors].
Grigor'eva GM; Krasnova TI; Khovanskikh AE
Zh Evol Biokhim Fiziol; 1990; 26(2):145-50. PubMed ID: 2375193
[TBL] [Abstract][Full Text] [Related]
12. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
Tunek A; Svensson LA
Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats.
Bajgar J
Acta Medica (Hradec Kralove); 2008; 51(4):223-8. PubMed ID: 19453088
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 1999 Dec; 386(1):7-13. PubMed ID: 10611458
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cetyltrimethylammonium on the human blood cholinesterases activity].
Kuznetsova LP; Samokish VA; Sochilina EE
Ukr Biokhim Zh (1999); 2011; 83(2):29-35. PubMed ID: 21851044
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.
Liston DR; Nielsen JA; Villalobos A; Chapin D; Jones SB; Hubbard ST; Shalaby IA; Ramirez A; Nason D; White WF
Eur J Pharmacol; 2004 Feb; 486(1):9-17. PubMed ID: 14751402
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers.
Loewenstein-Lichtenstein Y; Schwarz M; Glick D; Nørgaard-Pedersen B; Zakut H; Soreq H
Nat Med; 1995 Oct; 1(10):1082-5. PubMed ID: 7489367
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of cholinesterases by aziridinium derivatives of polymethylene bischloroethylamines].
Volkova RI; Kochetova LM
Bioorg Khim; 1983 Jul; 9(7):926-35. PubMed ID: 6679787
[TBL] [Abstract][Full Text] [Related]
20. Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.
Zawadzka A; Lozińska I; Molęda Z; Panasiewicz M; Czarnocki Z
J Pineal Res; 2013 May; 54(4):435-41. PubMed ID: 24325732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
